Loading...
•
Mar 31, 2023
Inogen Q1 2023 Earnings Report
Inogen's Q1 2023 revenue decreased by 10.2% year-over-year, but rental revenue increased by 25.4% due to higher rental patients on service and higher reimbursement rates. The company is focused on returning to profitability and anticipates positive adjusted EBITDA by Q4 2023.
Key Takeaways
Inogen's Q1 2023 revenue was $72.2 million, a 10.2% decrease compared to Q1 2022. However, rental revenue increased by 25.4%. The company reported a GAAP net loss of $20.3 million and is focused on returning to profitability.
Total revenue was $72.2 million, a decrease of 10.2% year-over-year, with currency fluctuations accounting for 1.7% of the decrease.
Rental revenue increased by 25.4% due to higher rental patients on service and higher reimbursement rates.
GAAP net loss was $20.3 million, adjusted net loss was $14.5 million, and adjusted EBITDA was a loss of $11.8 million.
Total covered lives increased to approximately 160 million with the addition of two large private healthcare payers.
Revenue by Segment
Forward Guidance
Inogen expects positive adjusted EBITDA by Q4 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...